Audentes Therapeutics, Inc.

Insider Reports History

Entity
Company
Location
600 California St., 17 Th Floor, San Francisco, CA
Signature
/s/ Chad Diehl, Attorney-in-Fact, Astellas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Audentes Therapeutics, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. 10%+ Owner Common Stock 7.27M $11.8M $1.63 Oct 21, 2022 Direct

Insider Reports Filed by Audentes Therapeutics, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSHA Taysha Gene Therapies, Inc. Oct 21, 2022 0 $0 3 Oct 31, 2022 10%+ Owner